Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.7 |
mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.023 | 0.7 |
mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |